Design Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Design therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Design Therapeutics Inc Today - Breaking & Trending Today

Design Therapeutics (NASDAQ:DSGN) Rating Increased to Overweight at Piper Sandler

Design Therapeutics (NASDAQ:DSGN) Rating Increased to Overweight at Piper Sandler
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Johnp Schmid , Piper Sandler , Hermes Inc , Securities Exchange Commission , Royal Bank , Nisa Investment Advisors , Simplicity Wealth , Design Therapeutics Inc , Bleakley Financial Group , Design Therapeutics , Get Free Report , Director John , Exchange Commission , Fire Capital , Investment Advisors , Design Therapeutics Daily ,

Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones

Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Pratik Shah , Upcoming Program Milestones , Exchange Commission , Development Candidates , Strategic Communications , Design Therapeutics Inc , Development For Fuchs Endothelial Corneal Dystrophy , Therapeutics Announces First Quarter , Highlights Upcoming Program , New Drug Product , Friedreich Ataxia , Toward Clinical , Fuchs Endothelial Corneal Dystrophy , Observational Study Currently Enrolling Patients , Myotonic Dystrophy , Support Multi Year Operating Runway , Four Programs , Anticipated Upcoming , Endothelial Corneal Dystrophy , Operating Runway , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , Months Ended March ,

Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference

CARLSBAD, Calif., May 07, 2024 Design Therapeutics, Inc. , a biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will. ....

New York , United States , Design Therapeutics Inc , Strategic Communications , Markets Healthcare Conference ,

Design Therapeutics, Inc. (NASDAQ:DSGN) Director Purchases $66,605.66 in Stock

Design Therapeutics, Inc. (NASDAQ:DSGN – Get Free Report) Director John P. Schmid purchased 17,809 shares of Design Therapeutics stock in a transaction dated Monday, March 25th. The shares were bought at an average price of $3.74 per share, with a total value of $66,605.66. Following the completion of the acquisition, the director now directly owns […] ....

United States , Johnp Schmid , Securities Exchange Commission , Group Plc , Nisa Investment Advisors , Design Therapeutics Inc , Tower Research Capital , Royal Bank , Design Therapeutics Company Profile , Hermes Inc , Design Therapeutics , Get Free Report , Director John , Exchange Commission , Fire Capital , Investment Advisors , Research Capital , General Group Plc , Design Therapeutics Daily , Nasdaq Dsgn , Insider Trading , Nsider Trades ,

John P. Schmid Acquires 9,156 Shares of Design Therapeutics, Inc. (NASDAQ:DSGN) Stock

Design Therapeutics, Inc. (NASDAQ:DSGN – Get Free Report) Director John P. Schmid acquired 9,156 shares of Design Therapeutics stock in a transaction on Friday, March 22nd. The stock was acquired at an average cost of $3.62 per share, for a total transaction of $33,144.72. Following the completion of the purchase, the director now owns 9,156 […] ....

United States , Johnp Schmid , Design Therapeutics Company Profile , Tower Research Capital , Securities Exchange Commission , Hermes Inc , Group Plc , Royal Bank , Nisa Investment Advisors , Design Therapeutics Inc , Design Therapeutics , Get Free Report , Director John , Exchange Commission , Fire Capital , Investment Advisors , Research Capital , General Group Plc , Design Therapeutics Daily , Nasdaq Dsgn , Insider Trading , Nsider Trades ,